Drugs / CORT125236
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05003713 | Aug 2021 → Feb 2023 | — | Corcept Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CORT125236 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05003713 ↗ |
| Route | Oral | “CORT125236 Lipid Capsule Formulation 10-60 mg for oral administration” NCT05003713 ↗ |